Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ELI LILLY & Co Director's Dealing 2026

Feb 18, 2026

29745_dirs_2026-02-18_b69a4de2-5aa4-48ed-aeaf-fe8b724a2d17.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ELI LILLY & Co (LLY)
CIK: 0000059478
Period of Report: 2026-02-16

Reporting Person: Brown Adrienne S (EVP, President LLY Imm)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2026-02-16 Common Stock M 391 Acquired 5312.308 Direct
2026-02-16 Common Stock F 169.966 $1040 Disposed 5142.342 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2026-02-16 Restricted Stock Unit $ M 391 Disposed 2026-02-16 Common Stock (391) Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.